Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators.

[1]  R. T. Lie,et al.  Neurohumoral measurements as indicators of long-term prognosis after acute myocardial infarction. , 1995, The American journal of cardiology.

[2]  S. Viskin,et al.  Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice. , 1995, Journal of the American College of Cardiology.

[3]  R. M. Rubison,et al.  Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. , 1994, Circulation.

[4]  J. Rouleau,et al.  Prognostic value of neurohumoral activation in patients with an acute myocardial infarction: effect of captopril. , 1994, Journal of the American College of Cardiology.

[5]  G. Lamas,et al.  Quantitative Two-Dimensional Echocardiographic Measurements are Major Predictors of Adverse Cardiovascular Events After Acute Myocardial Infarction: The Protective Effect of Captopril , 1994, Circulation.

[6]  K. Swedberg,et al.  Effects of ramipril on the neurohormonal response to exercise in patients with mild or moderate congestive heart failure. , 1994, European heart journal.

[7]  G. Lamas,et al.  Activation of neurohumoral systems in postinfarction left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.

[8]  I. Meredith,et al.  Cardiac Sympathetic Nervous Activit in Congestive Heart Failure Evidence for Increased Neuronal Norepinephrine Release and Preserved Neuronal Uptake , 1993, Circulation.

[9]  J. Cohn,et al.  Plasma Norepinephrine, Plasma Renin Activity, and Congestive Heart Failure Relations to Survival and the Effects of Therapy in V‐HeFT II , 1993, Circulation.

[10]  M. Bristow.  Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents. , 1993, The American journal of cardiology.

[11]  P. Held.  Effects of beta blockers on ventricular dysfunction after myocardial infarction: tolerability and survival effects. , 1993, The American journal of cardiology.

[12]  E. J. Brown,et al.  Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.

[13]  J. Dimsdale,et al.  Plasma Atrial Natriuretic Peptide Is Unstable Under Most Storage Conditions , 1992, Circulation.

[14]  M. Pfeffer,et al.  Rationale, design and baseline characteristics of the survival and ventricular enlargement trial , 1991 .

[15]  J. Fleiss,et al.  Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group. , 1990, Journal of the American College of Cardiology.

[16]  K. Swedberg,et al.  Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.

[17]  F. Klocke,et al.  Guidelines for the early management of patients with acute myocardial infarction , 1990 .

[18]  F. Klocke,et al.  ACC/AHA guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (subcommittee to develop guidelines for the early manag , 1990, Circulation.

[19]  I. Wiklund,et al.  Physical inactivity as a risk factor for primary and secondary coronary events in Göteborg, Sweden. , 1988, European heart journal.

[20]  R. Byington,et al.  Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. , 1986, Circulation.

[21]  J. Rouleau,et al.  Differential long-term intrarenal and neurohormonal effects of captopril and prazosin in patients with chronic congestive heart failure: importance of initial plasma renin activity. , 1986, Circulation.

[22]  J. Wade,et al.  Heterologous radioimmunoassay of atrial natriuretic polypeptide in dog and rabbit plasma. , 1986, Journal of immunoassay.

[23]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[24]  J. Cohn,et al.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. , 1984, The New England journal of medicine.

[25]  T. Gundersen.  Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction. , 1983, British heart journal.